Shangri-La Healthcare Investment is dedicated to long-term investment in Vietnam’s advanced medical technology, aiming to establish the country as a leading healthcare hub in the ASEAN region, said the Singaporean firm’s representative.
Party General Secretary To Lam met with Tran Thi Lam, advisor to Shangri-La Healthcare Investment and co-founder of Hoa Lam Shangri-La Medical Co., Ltd., along with the company’s leadership on March 11, as part of his ongoing visit to the city state from March 11 to 13.
At the working session, Tran Thi Lam presented Shangri-La Healthcare Investment’s investment journey in Vietnam, highlighting the HCMC High-Tech Medical Zone project—one of the largest and pioneering private healthcare initiatives in the country.
In 2008, the firm partnered with Hoa Lam Group to develop the HCMC High-Tech Medical Zone, with a total investment of US$400 million over an area of 37 hectares.
To date, eight out of 22 planned components have been completed, including City International Hospital (320 beds), Gia An 115 Hospital (367 beds), Aeon Mall Binh Tan shopping center, three parks, and the overall technical infrastructure of the zone.
For the 2025-2030 period, the firm is committed to investing an additional US$300 million to complete the remaining components of the project. These include a general hospital, a medical and pharmaceutical university, three residential areas, and two kindergartens.
“We are committed not only to completing the entire HCMC High-Tech Medical Zone project but also to continuing our investments in advanced medical technology, contributing to making Vietnam a leading healthcare hub in the ASEAN region,” she emphasized.
Shangri-La Healthcare Investment is also preparing a proposal to submit to the Vietnamese Ministry of Health for the implementation of a proton therapy system—one of the most advanced technologies in cancer treatment today.
Alongside equipment investment, the company is proposing a partnership with international counterparts to transfer proton therapy technology, with the goal of enabling Vietnam to become self-sufficient in cancer treatment technology in the future.
Investing in advanced medical technology, particularly proton therapy, not only enhances the quality of cancer treatment in Vietnam but also enables local patients to access high-quality healthcare services without having to go abroad, she said.
Party General Secretary To Lam highly appreciated the contributions of Shangri-La Healthcare Investment in Vietnam. He also affirmed that Vietnam always welcomes and facilitates foreign investors, especially those from Singapore.
“The Vietnamese government is committed to supporting and creating favorable conditions for Singaporean enterprises, including Shangri-La Healthcare Investment, to continue investing and achieving business success in Vietnam,” he noted.
As of February 28, 2025, Singapore ranks second among the largest investors in Vietnam, with 3,983 projects totaling over US$84.4 billion. Vietnam remains attractive to Singaporean investors due to its stable investment climate, supportive policies, growing private healthcare sector, and a strong focus on digital transformation and advanced medical technology.
